Related Experiment Video
Updated: May 31, 2025

Three-Dimensional Culture of Murine Colonic Crypts to Study Intestinal Stem Cell Function Ex Vivo
Published on: October 11, 2022
Claudins as diagnostic tools and therapeutic targets-Glimpse of the horizon
1Gastrointestinal Unit, Department of Medicine, Royal Marsden Hospital, London and Surrey, UK; Department of Medical Oncology, NHO Nagoya Medical Center, Nagoya, Aichi, Japan.
Abstract:
Claudins (CLDNs) play a crucial and indispensable role as fundamental components within the structure of tight junctions. Due to the distinct and unique distribution pattern exhibited by CLDNs in both normal and malignant tissues, these proteins have garnered significant attention as pivotal targets for systemic anti-cancer therapy and as noteworthy diagnostic markers. This review provides a comprehensive and detailed elucidation of the fundamental understanding surrounding CLDNs, their intricate expression patterns, the potential role they play in cancer diagnosis and therapeutic potentials; all encapsulated within a succinct summary of the cutting-edge advancements and the information derived from various clinical trials.
Insights
Claudins (CLDNs) are key tight junction proteins. Their unique expression in normal and cancerous tissues makes them promising targets for cancer diagnosis and therapy, with recent clinical trials showing advancements.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Claudins (CLDNs) are integral membrane proteins forming the backbone of tight junctions.
- Tight junctions regulate paracellular permeability and maintain cell polarity.
- Aberrant CLDN expression is a hallmark of many human cancers.
Purpose of the Study:
- To provide a comprehensive review of Claudins (CLDNs) in cancer.
- To elucidate the role of CLDNs in cancer diagnosis and therapeutic strategies.
- To summarize recent advancements and clinical trial outcomes related to CLDNs.
Main Methods:
- Literature review of fundamental Claudin (CLDN) biology.
- Analysis of CLDN expression patterns in normal and malignant tissues.
- Synthesis of data from preclinical studies and clinical trials involving CLDNs.
Main Results:
- Claudins (CLDNs) exhibit diverse expression profiles correlating with tissue type and malignancy.
- Specific CLDNs are validated as diagnostic biomarkers for various cancers.
- Targeting CLDNs shows potential for novel systemic anti-cancer therapies.
Conclusions:
- Claudins (CLDNs) are critical regulators of tight junction integrity and cellular function.
- Their distinct expression patterns offer significant opportunities for cancer biomarker development.
- CLDN-targeted therapies represent a promising frontier in oncology, supported by emerging clinical evidence.
More Related Videos
06:43Functional Assessment of Intestinal Tight Junction Barrier and Ion Permeability in Native Tissue by Ussing Chamber Technique
Published on: May 26, 2021
07:47A Proteoliposome-Based Efflux Assay to Determine Single-molecule Properties of Cl- Channels and Transporters
Published on: April 20, 2015
Related Concept Videos
Tight Junctions
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Gap Junctions
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...